Mayo Clinic Laboratory and pathology research roundup: January 31 - Insights

This week's research roundup features: Emergence of restless legs syndrome during opioid discontinuation

Mayo Clinic Laboratory and pathology research roundup: February 15 - Insights

This week's Research Roundup features: Activity of a hypochlorous acid-producing electrochemical bandage as assessed with a porcine explant biofilm model.

Mayo Clinic Laboratory and pathology research roundup: February 28 - Insights

This week's Research Roundup features: Laboratory and metabolic investigations.

Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights

This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Mayo Clinic Laboratory and pathology research roundup: June 27 - Insights

This week's research roundup feature: SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.

Mayo Clinic Laboratory and pathology research roundup: August 8 - Insights

This week's research roundup feature: Age-based versus young-adult thresholds for nephrosclerosis on kidney biopsy and prognostic implications for CKD.

Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights

This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights

In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

Diagnostic ecosystem boosts access to timely Alzheimer's disease testing - Insights

Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic...